Nivolumab and Ipilimumab in Advanced Melanoma
N Engl J Med
.
2017 Dec 21;377(25):2503.
doi: 10.1056/NEJMc1714339.
Authors
Hyewon Ryu
1
,
Hyo Jin Lee
Affiliation
1
Chungnam National University College of Medicine, Daejeon, South Korea cymed@cnu.ac.kr
PMID:
29265785
DOI:
10.1056/NEJMc1714339
No abstract available
Publication types
Letter
Comment
MeSH terms
Antibodies, Monoclonal*
Humans
Ipilimumab*
Melanoma
Nivolumab
Substances
Antibodies, Monoclonal
Ipilimumab
Nivolumab